• Utah Medical Products corrected its tender offer communications, confirming the offer expires at 5:00 p.m. New York time on Oct. 7.
• Prior statements misidentified Oct. 7 as a Tuesday; the company clarified the date falls on a Wednesday.
• The tender offer seeks up to 650,000 common shares at USD 75 per share, unless extended.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609251100ACCESSWRNAPR_____1227170) on September 25, 2026, and is solely responsible for the information contained therein.